使用解吸电喷雾电离质谱法术中评估人脑胶质瘤的异柠檬酸脱氢酶突变状态
该研究利用解吸电喷雾电离质谱(DESI-MS)检测胶质瘤组织中2-羟基戊二酸(2HG),在37例库存标本中建立方法,并在25例患者(14例野生型、11例突变型)的51份肿瘤核心活检中术中快速诊断IDH突变状态(<5分钟),平均敏感度和特异度均为100%。
要点
- DESI-MS可在5分钟内术中检测胶质瘤IDH突变状态,平均敏感度和特异度均为100%。
- IDH突变型胶质瘤的平均归一化DESI-MS 2HG信号比IDH野生型高一个数量级。
- DESI 2HG信号强度与独立测定的2HG浓度相关(R²=0.98)。
核心结论
- DESI-MS可在肿瘤切除过程中快速区分IDH突变型胶质瘤与IDH野生型病变。
- 组织涂片的DESI-MS分析简单,可容易地整合到标准术中病理会诊中。
- 该方法可能有助于解决低级别胶质瘤的鉴别诊断问题,并可能影响关于切除范围的术中决策,最终改善患者结局。
- 正在开展研究以扩大患者队列、系统验证DESI-MS方法并探究2HG与肿瘤异质性之间的关系。
研究设计与样本
- 研究分析了37例库存胶质瘤标本,通过DESI-MS建立检测IDH突变型胶质瘤中已知改变的肿瘤代谢物2-羟基戊二酸(2HG)的诊断方法。
- 该方法术中用于分析接受切除术的胶质瘤患者组织涂片,快速诊断IDH突变状态(<5分钟)。
- 检查了25例患者(14例野生型[WT]和11例突变型)的51份肿瘤核心活检,数据采用方差分析和受试者工作特征曲线分析。
主要发现
- 优化的DESI-MS方法可区分IDH-WT与IDH突变型胶质瘤,平均敏感度和特异度均为100%。
- IDH突变型胶质瘤的平均归一化DESI-MS 2HG信号比IDH-WT胶质瘤高一个数量级。
- DESI 2HG信号强度与独立测定的2HG浓度相关(R²=0.98)。
- 1例IDH1 R132H突变型胶质瘤在术中会诊时被冰冻切片组织学误诊为脱髓鞘病变,未行切除而等待最终病理报告;最终病理诊断最符合IDH突变型胶质母细胞瘤后,行第二次开颅肿瘤切除术,术中在肿瘤核心活检中检测到高水平2HG。
局限性
- 研究正在进行以扩大患者队列。
- 研究正在进行以系统验证DESI-MS方法。
- 研究正在进行以探究2HG与肿瘤异质性之间的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors describe a rapid intraoperative ambient ionization mass spectrometry (MS) method for determining isocitrate dehydrogenase (IDH) mutation status from glioma tissue biopsies. This method offers new glioma management options and may impact extent of resection goals. Assessment of the IDH mutation is key for accurate glioma diagnosis, particularly for differentiating diffuse glioma from other neoplastic and reactive inflammatory conditions, a challenge for the standard intraoperative diagnostic consultation that relies solely on morphology. METHODS: Banked glioma specimens (n = 37) were analyzed by desorption electrospray ionization-MS (DESI-MS) to develop a diagnostic method to detect the known altered oncometabolite in IDH-mutant gliomas, 2-hydroxyglutarate (2HG). The method was used intraoperatively to analyze tissue smears obtained from glioma patients undergoing resection and to rapidly diagnose IDH mutation status (< 5 minutes). Fifty-one tumor core biopsies from 25 patients (14 wild type [WT] and 11 mutant) were examined and data were analyzed using analysis of variance and receiver operating characteristic curve analysis. RESULTS: The optimized DESI-MS method discriminated between IDH-WT and IDH-mutant gliomas, with an average sensitivity and specificity of 100%. The average normalized DESI-MS 2HG signal was an order of magnitude higher in IDH-mutant glioma than in IDH-WT glioma. The DESI 2HG signal intensities correlated with independently measured 2HG concentrations (R2 = 0.98). In 1 case, an IDH1 R132H-mutant glioma was misdiagnosed as a demyelinating condition by frozen section histology during the intraoperative consultation, and no resection was performed pending the final pathology report. A second craniotomy and tumor resection was performed after the final pathology provided a diagnosis most consistent with an IDH-mutant glioblastoma. During the second craniotomy, high levels of 2HG in the tumor core biopsies were detected. CONCLUSIONS: This study demonstrates the capability to differentiate rapidly between IDH-mutant gliomas and IDH-WT conditions by DESI-MS during tumor resection. DESI-MS analysis of tissue smears is simple and can be easily integrated into the standard intraoperative pathology consultation. This approach may aid in solving differential diagnosis problems associated with low-grade gliomas and could influence intraoperative decisions regarding extent of resection, ultimately improving patient outcome. Research is ongoing to expand the patient cohort, systematically validate the DESI-MS method, and investigate the relationships between 2HG and tumor heterogeneity.
引用
- Alfaro CM, Pirro V, Keating MF, et al. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry. J Neurosurg. 2019. PMID: 30611146. doi:10.3171/2018.8.JNS181207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。